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Helminth parasites are masters at manipulating host immune responses, using an array
of sophisticated mechanisms. One of the major mechanisms enabling helminths to
establish chronic infections is the targeting of pattern recognition receptors (PRRs)
including toll-like receptors, C-type lectin receptors, and the inflammasome. Given
the critical role of these receptors and their intracellular pathways in regulating
innate inflammatory responses, and also directing adaptive immunity toward Th1
and Th2 responses, recognition of the pathways triggered and/or modulated by
helminths and their products will provide detailed insights about how helminths are
able to establish an immunoregulatory environment. However, helminths also target
PRRs-independent mechanisms (and most likely other yet unknown mechanisms
and pathways) underpinning the battery of different molecules helminths produce.
Herein, the current knowledge on intracellular pathways in antigen presenting cells
activated by helminth-derived biomolecules is reviewed. Furthermore, we discuss the
importance of helminth-derived vesicles as a less-appreciated components released
during infection, their role in activating these host intracellular pathways, and their
implication in the development of new therapeutic approaches for inflammatory diseases
and the possibility of designing a new generation of vaccines.
Keywords: extracellular vesicle, helminths, immunosuppression, intracellular pathways, pattern recognition
receptors
INTRODUCTION
Host-Parasite Interactions (Live Infection, Excretory Secretory
Molecules, and Extracellular Vesicle)
Parasitic worms (helminths) constitute a very successful group of pathogens that have evolved a
number of unique host adaptations (1). Despite their large size, and local or systemic migration
throughout the host body, the worms only elicit limited inflammation in invaded tissues and install
an immunoregulatory environment which ensures their survival (1). Such a masterful adaption is
ascribed to their long coevolution with the hosts enabling them to perform an effective modulation
of the immune system (2). Of note, this mutual relationship between worm and host evolves
to reciprocal beneficial outcomes, as deworming can result in the emergence of immune-related
disorders along with clinical manifestations (3). Various mechanisms have been identified by
which helminths restrain host immune responses including expansion of regulatory cells (4),
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induction of apoptosis in immune cells (5), manipulation of
pattern recognition receptors (PRRs) and downstream signaling
(6), and suppression of Th1/Th2 cells and associated cytokines
(7). However, there are likely to still be complex and unknown
aspects of the strategies underpinning this sophisticated interface
which are yet to be investigated (8).
In recent years, the regulatory functions of helminths and
their potential ability to ameliorate inflammatory diseases have
received much interest (8). Seminal research in this area mostly
derives from the hypothesis of Strachan et al. who suggested an
inverse relationship between sanitation and prevalence of allergy
in different societies, the so-called “hygiene hypothesis” (9, 10).
Based on this hypothesis, changes in or eradication of infections
can lead to dysregulation of host immune responses, paving the
way for allergic and autoimmune disorders (11).
A number of animal models along with some human pilot
studies have evaluated the effects of live helminth infections
on various inflammatory and autoimmune diseases, such as
experimental autoimmune encephalomyelitis (12), asthma (13,
14), anaphylaxis (15) and inflammatory bowel disease (IBD)
(16, 17). These experimental studies provided promising results
concerning the beneficial effects of helminth infections on allergic
and autoimmune diseases through stimulation of Treg cells,
activation of toll-like receptor (TLRs), and induction of anti-
inflammatory cytokines, such as TGFβ and IL-10 (18). Promising
results obtained in both human and animal studies prompted
clinical evaluations (16), but due to potential deleterious
consequences and side effects which live worms may cause for
humans, investigations have also focused on characterizing and
recognition of helminth-derived products (HDPs) via exploiting
high-throughput assays and omics-based techniques, such as
proteomics (19, 20).
There are a number of studies indicating that many
HDPs possess immunoregulatory properties. For example, the
tapeworm, Echinococcus granulosus is able to bypass host
immunosurveillance and polarize immune response toward the
regulatory state (21). Antigen B (AgB) and sheep hydatid fluid
(SHF) are two major components by which E. granulosus
suppresses dendritic cell (DC) maturation and monocyte
differentiation, resulting in reduced anti-parasite responses (21).
Likewise, a well-known compound with remarkable regulatory
functions is the phosphorylcholine-containing glycoprotein, ES-
62 released by the filarial worm, Acanthocheilonema viteae,
which has widely been investigated by Harnett and collogues
(22). In addition, glycan-based compounds, such as Lacto-N-
fucopentaose III /LewisX from helminths have been found to
be central molecules eliciting Th2 responses and orchestration
of immunoregulation through the involvement of C-type
lectin receptors (23). Interestingly, some worms, such as
the whipworm, Trichuris suis can forestall pro-inflammatory
responses in human DCs (24). T. suis has been found to
possess a high level of lipid-based biomolecules, such as
prostaglandin (PGE2) which impairs TLR4-associated myeloid
differentiation primary response protein 88 (MyD88) and the
TIR-domain-containing adaptor-inducing interferon-β (TRIF)
signaling (25, 26). Similarly, there is evidence showing that
helminth defense molecules contribute to immunomodulatory
outcomes of parasitic infections via targeting innate immunity
(27). However, the study of HDPs is still a major research area and
fractionating HDPs and subsequent detailed studies have opened
a new avenue for ongoing investigations.
Recently, extracellular vesicles (EVs) have emerged as a
previously unappreciated entity of HDPs which may play
a crucial role in parasite immunomodulation. These “magic
bullets” have encouraged investigators to unravel their role in
pathogenicity, invasion, and longevity of parasitic infections
(28). Currently, EVs have shown that may be central in the
host-parasite interplay and intracellular communication (29).
During infection, the immune system is constantly interacting
with a wide range of helminth-derived products including
EVs which eventually results in either immune stimulation
or immunoregulation. For example, it has recently been
documented that parasite EVs can manipulate macrophage
activation and regulate inflammatory responses (30, 31). The
intercellular delivery of EV-associated RNAs, such asmicroRNAs,
has identified them as important means for inducing epigenetic
modifications in intracellular signaling and post-transcriptional
regulation of gene expression (30, 32).
In this review, we aim to elaborate modulation of intracellular
pathways, mainly in antigen presenting cells (APCs), by which
HDPs polarize and suppress host immunity. Moreover, we
suggest that understanding the intracellular outcomes upon
interaction with HDPs will provide a broad insight into the
possible interactions between EVs (as an important component
of HDPs) and host intracellular machinery. The putative
pathways enabling EVs to impose immunomodulatory effects on
host immunity are highlighted. Furthermore, the implication of
these vehicles in the development of new therapeutic approaches
against inflammatory responses and possibilities of designing a
new generation of vaccines based on EVs are discussed.
HELMINTH-DERIVED PRODUCTS (HDPS)
AS POTENT IMMUNOMODULATORS
How HDPs Polarize Immune Responses by
Targeting Intracellular Pathways
Helminths have evolved sophisticated mechanisms to
target intracellular machinery in host cells (33). They have
shown a remarkable ability to induce a tolerogenic immune
microenvironment by releasing an array of bioactive materials
(33). A large body of literature has identified HDPs as powerful
modulators of inflammatory signals comprising an impressive
range of molecular pathways elicited against parasites (33).
HDPs, in total and as individual compounds, play a central role
establishing a beneficial niche for the parasite via an effective
manipulation of the host immunity to engage a receptor, degrade
intracellular molecules, and interfering with essential signals
(34). However, the majority of intracellular pathways targeted by
these biomolecules are poorly described, but in the following,
we focus on innate receptors as important sensors which are
targeted by HDPs.
Pattern recognition receptors (PRRs) are one of the most
important immune receptors, and their signaling is now
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becoming more apparent in regulation of immune responses
(35). PRRs are a family of highly sensitive extra and intracellular
sensors including Toll-like receptors (TLRs), nucleotide-
binding oligomerization domain (NODs)-like receptors (NLRs),
retinoic acid-inducible gene-like receptors (RIG-like receptors),
and C-type lectin receptors (CLRs) (35). They are widely
expressed by immune cells, in particular, those responsible for
immunosurveillance, such as DCs and macrophages. PRRs are
able to trigger a complex of intracellular crosstalk resulting in
DC maturation and T cell priming (36).
Since HDPs are mostly rich in glycan-based products,
such as glycoprotein along with lipid structures, TLRs and
CLRs have been found to be predominantly targeted by these
antigens during immunomodulation and hyporesponsiveness
(37). HDPs not only alter the expression of TLRs but also
masterfully manipulate their intracellular signaling, reflecting a
strict control over host immunity by helminths (6). Interfering
with these intracellular pathways, which are main drivers for
priming inflammatory responses, suggests that these extracellular
parasites can release substances modulating early responding
cells in innate immunity (38). Despite the general view that
microbial components can engage PRRs and thereby activate
DCs, it is well-known that DCs exposed concurrently to HDPs
and TLR agonists, such as viral or bacterial products do often
not express markers associated with classical maturation (39,
40). For instance, murine DCs treated with soluble SEA fail to
express MHC-II, costimulatory molecules, and proinflammatory
cytokines in response to LPS (40). In the same way, the
release of antigen B (AgB) (a hydatid cyst-derived antigen)
by E. granulosus prevents upregulation of LPS-induced CD80,
CD86, and TNFα in DCs (21), monocytes, and macrophages via
an IL-10 independent manner (41).
Intriguingly, HDPs can alsomodulate TLRs signaling to prime
a tolerogenic phenotype of DCs that produce anti-inflammatory
cytokines (42). Schistosoma mansoni and released eggs can
produce bioactive antigens, such as lysophosphatidylserine,
lacto-N-fucopentaose III (LNFPIII), and double-stranded RNA
(dsRNA) which attenuate inflammatory responses by targeting
TLRs. LNFPIII has also been reported to induce DCs maturation
and Th2 response polarization through CLRs (23). Another
biomolecule that interacts with TLRs is ES-62 released by A.
viteae which targets TLR4 on host immune cells. ES-62 is able
to interfere with the downstream signalings mediated by TLR4,
and through which diminishes the production of inflammatory
mediators (22).
Likewise, many other HDPs, such as body fluid from
adult Ascaris suum, have also been documented to induce
hyporesponsiveness in human APCs treated with LPS and
modulate different human macrophage phenotypes (43, 44).
Although HDPs mainly seem to impair TLR4-associated
inflammatory responses, it appears that these components tend
to target manifold pathways in TLRs and CLRs signaling. Recent
bioinformatics-based data has suggested that HDPs constitute
a myriad of molecules with complex structures (20). Thus,
recognition of a target on DCs would be essential to dissect
and identify the major immunosuppressive functions. Here we
focus on the main PRR-associated intracellular machinery that is
altered by HDPs to favor helminth survival and persistence in the
host (Figure 1).
TLR Signaling (Map Kinases and Nf-κ B Cascade)
Mitogen-activated protein kinases (MAPKs) are a group of
highly important molecules orchestrating the production of
different cytokines via involving various downstream accessory
proteins in DCs (45). The MAPK pathway is one of the main
signaling cascades induced as a result of TLRs stimulation (45).
Different kinases contribute to MAPK signaling including the
extracellular signal-related kinases 1 and 2 (ERK 1/2), c-jun
NH2-terminal kinase (JNK), and p38 MAPK. Activation of these
molecules results in DC maturation, cytokine production, and
gene expression via stimulation of transcription factors, such as
activating protein 1 (AP-1), nuclear factor-κB (NF-κB), and IFN
regulatory factors (IRFs) (45). ERK1/2 signaling mostly mediates
Th2 response andDCs hyporesponsiveness due to stabilization of
the c-fos transcription factor which suppresses IL-12 production
(46, 47), whereas JNK and p38 are mostly associated with
Th1 responses and DCs activation (47). In support of this,
blocking ERK1/2 pathway by the specific inhibitor U0126 up-
regulates IL-12 and suppresses TLR2-induced IL-10 production
(47). Furthermore, it has been reported that ERK1 knockout mice
spontaneously develop autoimmunity (48). On the other hand,
two important adaptor molecules associated with TLRs signaling
are MyD88 and TRIF, and TLR-induced activation of these
molecules is responsible for the expression of genes encoding
inflammatorymediators, such as IL-12 and TNFα (36). A number
of helminths release molecules that are capable of triggering anti-
inflammatory responses via interference with these downstream
pathways (38, 49, 50). For example, soluble products of T. suis not
only suppress transcription of essential molecules orchestrating
both MyD88 and TRIF pathways in LPS-treated DCs, but also
restrain TLR4 expression preventing DC maturation (26). The
precise mechanisms by which HDPs influence these intracellular
events are currently the subject of intense investigation. However,
interesting data is becoming available regarding inhibitory effects
of some HDPs, such as ES-62 and LNFPIII on key molecules
involved in these inflammatory pathways.
One of the most important molecules that is targeted by
HDPs to subvert TLRs signaling is ERK1/2. This intracellular
component plays an essential role in mediation of anti-
inflammatory functions of ES-62 and LNFPIII. In fact, both
LNFP-III and ES-62, through engagement of TLR4 on DCs,
induce Th2 responses (38, 49, 50). Although the capacity
of TLR4 in skewing immune response toward Th2 seems
surprising, various mechanisms might be at play and might
explain the strikingly different response to LPS and some HDPs
(51). The main explanations for this phenomenon are selective
stimulation of ERK1/2 signaling and involvement of different
co-receptors by HDPs which eventually interfere with TLR4-
induced inflammatory signals in DCs (38, 51). In addition,
it should be noted that TLR4 signaling can be conducted by
two distinct of adaptor molecule pathways (TRIF and MyD88),
however, it is still obscure which adaptor molecule is responsible
for induction of immunoregulatory signals and how it is
selectively activated by HDPs (38).
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FIGURE 1 | Involvement of TLRs and CLRs during interaction with HDPs. TLRs and CLRs are widely targeted by HDPs during induction of immunomodulation and
hyporesponsiveness in APCs. HDPs not only alter the expression of TLRs and CLRs in APCs but also masterfully manipulate their intracellular signaling. Some HDPs
are able to redirect TLR4 signaling toward MAPK pathway and ERK1/2 activation supporting Treg/Th2 induction. In addition, co-engagement of DC-SIGN along with
TLR4 enables HDPs to trigger unknown intracellular pathways which cross-inhibit MyD88 and NFκB activation. HDPs can further restrain NFκB activity via
DC-SIGN-mediated RAF signaling along with upregulation of negative regulators of TLRs signaling, such as SOCSs and PI3K. Obviously, strict inhibition of NFκB as
the main transcription factor supporting inflammation results in prevention of priming Th1 cells. Other CLRs have been reported to participate in priming Treg/Th2 cells
upon stimulation by HDPs. For example, some HDPs suppress phosphorylation of Dectin1/2-induced Syk molecule and through which inhibit deviation of immune
response toward Th1. On the other hand, MR and MGL upon activation by HDPs through an unknown mechanism support Treg/Th2 differentiation. Degrading host
key intracellular molecules is another strategy that HDPs exploit to reprogram host immunity. Omega-1, ES-62, and FheCL1 by degrading host mRNA, endosomal
TLR4, and TLR3, respectively, not only strengthen Treg/Th2 responses but also forestall anti-parasite immunity. NLRP3 also has been revealed to be targeted by some
HDPs to modulate inflammatory responses. However, there has been reported that some HDPs are able to fight anti-worm immunity by stimulation of NLRP3 leading
to release of IL-1B and Th1 amplification.
There is strong evidence that activation of ERK1/2 signaling
inhibits a Th1 response and instead polarizes immune responses
toward anti-inflammatory and Th2 response both in vivo
and in vitro (45, 52). LNF-PIII is one the most powerful
HDPs in supporting ERK signaling which significantly induces
phosphorylation of ERK and TLR4-dependent differentiation
of naive DCs to a DC2 phenotype (50). It seems that such
a dysregulation of TLR signaling with a bias toward ERK1/2
is an effective strategy employed by the parasite to suppress
Th1 responses and polarization of host immunity. In addition,
Trichinella spiralis muscle larvae secrete bioactive components
which strongly induce transient ERK1/2 signaling, thereby
priming Th2/Treg-inducing DCs (53). However, different stages
of this nematode have also been shown to arrest NF-κB
translocation and the phosphorylation of p38 and ERK1/2 in
LPS-treated J774A.1 murine macrophage cell line (54).
To further explore the mechanism of these biomolecules on
immune cells, it is necessary to compare the signaling pathway(s)
triggered by these antigens and LPS (38). First, stimulation of
TLR4 by LPS results in triggering three different aforementioned
MAPK cascades (ERK1/2, JNK, and p38MAP kinases) along with
NF-κB pathway activation which ultimately leads to the release of
pro-inflammatory mediators (55). In contrast to the response to
LPS, it has been shown that LNFPIII and ES-62 are able to induce
mainly ERK1/2 signaling without significant stimulation of p38
and JNK. Second, furthermolecular dissection revealed that these
HDPs not only slightly activate NF-κB signaling relative to LPS,
but also shorten NF-κB longevity by stabilizing its inhibitor
(50, 56). Third, the suppressive functions of ES-62 have been
ascribed to inhibition of p38 and JNK, which play a central
role in the production of Th1-associated cytokines, such as IL-
12, IL-6, and TNFα (56, 57). Fourth, it should be noted that
another explanation for such a difference in signal transduction
between LPS and ES-62 might be due to the discrepancy in
ubiquitylation of TLR4 and/or downstream signaling complexes
(57). These data support the notion that some HDPs can elicit
Th2 response by TLR4 stimulation in a manner distinct from
customary agonists like LPS, which is a strong Th1 inducer.
The modulatory effects of ES-62 are not restricted only to
the skewing of TLR4 signaling toward ERK1/2. Melendez et al.
showed that ES-62 can also degrade key molecules involved in
FcεRI signaling onmast cells via TLR4 engagement (58). Multiple
downstream molecules are activated upon binding IgE to FcεRI,
such as protein kinase Cα (PKCα), phospholipase D-coupled, and
sphingosine kinase 1 (SPHK1) which subsequently trigger NF-
κB signaling. In comparison to LPS, which strengthens (FcεRI)-
mediated signaling, ES-62 directs PKCα toward degradation
via a TLR4-dependent and proteasome-independent manner,
suppressing mast cell activation in response to IgE stimulation
(58). Importantly, other members of the PKC family (PKCβ,
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PKCδ, PKCι, and PKCζ) can also be degraded by ES-62 (58, 59).
Among them, PKCδ is regarded as a TLR4-mediated pathway
molecule, which plays an important role in full activation
of LPS-induced inflammation (60). Eason et al. have recently
reported that despite LPS, ES-62 can exert downregulation and
autophagolysosomal degradation of PKCδ in DCs to undergo
autophagy (60).
Finally, a significant discrepancy between LPS and ES-62
stimulation of TLR4 relates to intracellular trafficking of this
receptor. It has been shown that ES-62 can trigger TLR4
trafficking to a distinct caveolae lipid raft route leading to
TLR4 degradation, whereas the route through which LPS
induces TLR4 trafficking is associated with the promotion of
Th1 and inflammatory responses (58) . Owing to promising
results achieved from ES-62, analog molecules of ES-62 termed
11a, 11e, 11i, and 12b have been synthesized by Harnett
and colleagues. These synthetic structures could experimentally
suppress collagen-induced arthritis (CIA) by downregulation of
key adaptor molecules in TLRs signaling, such as MyD88 and
NF-κB (61–63).
Of note, other helminthes, such as S. mansoni and Ascaris
lumbricoides can induce an imbalance in the intracellular
signaling of LPS-treated human DCs via engagement of TLR2
and high stimulation of the ERK pathway. Given the fact that
ERK1/2 signaling can increase c-Fos stabilization and IL-12
inhibition (47), it has been demonstrated that S. mansoni and A.
lumbricoides-derived phospholipids support Th2 polarization via
induction of imbalance in TLR2 signaling by strengthening ERK
pathway in human monocyte-derived DCs (64). Interestingly,
soluble SEA through TLR2 signaling induces a crosslink
manipulation on the expression of co-inhibitory-associated
genes, such as programmed death-ligand 1 (PD-1) and PD-L2 on
murine BMDCs and CD4+ T cells, respectively. Upregulation of
PD-1 and PD-L2 expression by egg antigens is a TLR2-dependent
mechanism leading to anergy and hyporesponsiveness during
interaction between macrophages and CD4+ T cells (65).
In addition, Correale et al. have suggested that SEA can
activate several genes associated with retinoic acid synthesis, such
as SOCS3 and IL-10R in DCs, via engagement of TLR2 and
activation of ERK1/2 signaling (66). Importantly, egg antigen-
treated DCs have been shown to strongly prime Tregs and
suppress production of inflammatory cytokines, indicating a
clear polarization by targeting TLR signaling. Mechanistically,
Agrawal et al. suggested that immunoregulatory function of egg
antigen is mediated via ERK1/2-induced c-Fos phosphorylation,
as in the absence of c-Fos immune response were redirected
toward Th1 (47).
Moreover, some HDPs, such as egg antigens condition DCs
to prime Foxp3 Tregs via TLR2-dependent ERK1/2 signaling.
This effect can also be observed with the antigen SJMHE1
from S. japonicum which increases proliferation and suppressive
functions of Tregs by activating TLR2 (67–69). However, it is
unknown how HDPs modify TLRs on Tregs to optimize their
lifespan and suppressive activity, so further research is required
to document the underlying molecular mechanism. Generally,
TLRs signaling is mediated through two distinct pathways known
as MAPK and NF-κB cascade. NF-κB signaling also plays an
essential role in priming Th2 response, since the lack of NF-κB in
DCs has been shown to result in Th2 impairment in the presence
of egg antigens and LNFPIII (70, 71).
SOCSs, JAK/STAT, and PI3K
There is evidence suggesting that some HDPs can directly
manipulate molecules controlling TLRs signaling, such as
suppressor of cytokine signaling 3 (SOCS3) (66, 72). In this
regard, it has been shown that F. hepatica produces biomolecules,
such as tegumental coat antigens (FhTeg) and cathepsin L1
cysteine protease (FheCL1) which are capable of interfering
with both the NF-κB and ERK/MAPK pathways in a manner
distinct from other HDPs (72, 73). For instance, FhTeg can
diminish the expression of inflammatory mediators in LPS-
treated DCs via upregulation of a negative regulator of the TLRs
pathway known as SOCS3 (72). On the other hand, FheCL1
is involved in neutralizing TLR3 signaling, as a TLR utilizing
TRIF adaptor as an activator of downstream molecules. In
fact, Donnelly et al. indicated that TRIF-dependent MyD88-
independent signaling pathway is impaired by FheCL1 via
degradation of TLR3 (73). Similar to FheCL1, SmCB-1 from S.
mansoni has been found to enter the endosome and degrade
TLR3. The protective effects of these antigens (FheCL1 and
SmCB-1) against LPS-induced lethality were found to be
mediated through MyD88-independent and TRIF-dependent
pathways shared by both TLR4 and TLR3, suggesting the
potential of HDPs as druggable targets due to their ability to
disrupt intracellular pathways activated during inflammation
(73). The TRIF-dependent pathway of TLR4 signaling can also
be inhibited by T. spiralis-derived antigens as a mechanism to
orchestrate regulatory responses (74). Brugia malayi has also
been shown to produce a component known as abundant larval
transcript (ALT-2) which promotes type 2 immune response and
attenuates IFN-dependent signals via activation of GATA-3 and
SOCS-1 in macrophages (75). SOCS-1 has also been reported to
be upregulated by SEA in human DCs exposed to LPS which was
associated with inhibition of pro-inflammatory cytokines (76).
Apart from ES-62, another well-known and highly bioactive
component from A. viteae with significant intracellular activity
is AvCystatin (77). Generally, cystatins are regarded as protease
inhibitors which have been detected in excretory-secretory
products of most filarial nematodes (78). Macrophages and IL-10
have been found to be central in the immunoregulatory effects
of AvCystatin on experimental models of colitis and asthma
(77, 79). AvCystatin is able to induce regulatory macrophages
(Mreg) representing remarkable suppressive effects on DCs
via IL-10 dependent and cell-contact independent mechanism
(79). Klotz et al. identified the molecular mechanism by which
AvCystatin can reprogram the macrophage phenotype and
suppresses inflammation. They suggest that AvCystatin is taken
up by macrophages and through stimulation of dual specificity
phosphatases (DUSPs), which are negative regulators of MAPK
signaling and IL-10 expression, targets ERK1/2 and p38 to
modulate downstream signals inducing regulatory responses
(77). Through this mechanism, the immunoregulatory effects of
AvCystatin are mediated via the phosphorylation of the CREB
and STAT3 (77). In addition, some HDPs, such as dsRNA
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derived from S. mansoni egg can also modulate STAT1 signaling
(80). This dsRNA is able to engage TLR3 and phosphorylate
STAT1 in DCs supporting signaling pathway associated with
type I IFN expression (80). Yang et al. have recently provided
evidence suggesting that the immunomodulatory activity of
S. mansoni egg antigens (SEA) and S. japonicum worm antigen
(SWA) in myeloid-derived suppressor cells (MDSCs) is mediated
through the Janus kinase/signal transducers and activators of
transcription 3 (JAK/STAT3) pathway (81). They corroborated
their findings by application of a JAK inhibitor (JSI-124) which
abrogated immunomodulatory functions of SEA and SWA (81).
Besides STAT1 and 3, STAT6 signaling has also been found
to be manipulated by some HDPs, such as T. spiralis-derived
cathepsin B-like protein (82). Liu et al. indicated that the
recombinant form of this antigen (rTsCPB) can significantly
restrain intestinal ischemia/reperfusion injury in mice by active
reprogramming macrophages from an inflammatory (M1) to an
alternative phenotype (M2) (82). One of the main intracellular
signalings for such a phenotypic alteration is activation of
STAT6 in M1 macrophages (82). Mechanistically, rTsCPB was
shown to support upregulation of M2-associated markers and
subsequently transition of M1 to M2 macrophage via STAT6-
dependent manner, as inhibition of STAT6 restored disease
severity and M1 domination (82).
Some parasites tend to target another pathway in TLR
signaling known as phosphoinositide 3-kinase (PI3K) which
is a strong inhibitor of TLR-induced IL-12 production and
DCs maturation (77, 83, 84). Accordingly, this pathway has
been revealed to shape immune response toward Th2 and
IL-10 production. For instance, some protozoan parasites,
such as Giardia lamblia and Leshmania major, along with A.
vitae, are able to interfere with TLR-mediated DCmaturation
via stimulation of PI3K signaling maturation (77, 83, 84).
Importantly, both CLRs and TLRs can share ERK and PI3K
signaling to redirect immune response toward Th2 during
infection with helminths (85).
These data show how HDPs may impact TLR signaling,
thereby bypassing inflammatory responses. The predominant
pathway triggered by HDPs is ERK1/2 signaling which supports
phosphorylation of the transcription factor c-Fos inducing
modified Th2 and/or anti-inflammatory responses (46, 50, 56).
Generally, it seems that one of the main mechanisms by which
helminths minimize host tissue injury is suppression of innate
immunity via modification of TLR signaling (6, 85).
C-Type Lectins Receptor (CLRs) Signaling
There is evidence suggesting the commencement of Th2
response can be initiated independent of the two adaptor
proteins MyD88 and TRIF (86). In this case, it is expected
that other PRRs beside TLRs also can initiate the Th2
response (37). As mentioned above, APCs express an array
of receptors known as CLRs specialized in the recognition
of glycans (87). CLRs can mediate different immunological
processes including antigen uptake, intracellular trafficking, and
priming innate immunity (87). Various types of CLRs are
expressed by APCs including DC-specific ICAM-3 grabbing
nonintegrin (DC-SIGN), macrophage galactose binding lectin
receptor (MGL), mannose receptor (MR), and Dectin-1. DC-
SIGN is involved in recognition of high mannose glycans and
is able to stimulate TLR signaling (87). MGL and MR detect
pathogens-associated mannose-containing glycans with high
sensitivity (87). Recently, surfactant protein (SP)-D, collectin
related to the family of C-type lectins, has also been reported
to interact with carbohydrate-based compartments of worms,
such as Nippostrongylus brasiliensis in the lung (88). Thawer
et al. demonstrated that SP-D KO mice are unable to control
N. brasiliensis in the lung, as this protein plays a key role
in stimulation of Th2 responses and alternative activation of
alveolarmacrophages (alvM) which is essential for binding to and
killing L4 parasites (88).
Importantly, CLRs play an important role in host-parasite
interaction through recognition of glycan-based components
in helminth-derived antigens (89). These parasite-derived
glycans constitute versatile glycoconjugates with highly various
structures targeting CLRs, and in turn skew adaptive immunity
(90). For instance, N-linked glycoconjugates from A. suum
extract engage DC-SIGN and MR to suppress LPS-induced DCs
maturation and triggering inflammatory signals (89). Similarly, it
has been shown that DC-SIGN, MR, and MGL can be involved
in capturing and internalization of SEA (91–93). Also, some
HDPs are quite similar to host glycans which, during interplay
with CLRs of DCs, induce both Th2 suppression and Treg
proliferation, establishing a tolerogenic state in host immune
function (94). In this way, this mechanism can create a balance
between Th1 and Th2 responses through the involvement of
CLRs on DCs (37, 95). Unfortunately, limited data are available
on the parasite components inducing immunological bias via the
involvement of CLRs.
One of the main pathways shared by most CLRs to trigger
downstream signaling is the spleen tyrosine kinase (Syk)
pathway, which has been shown to contribute to DC priming
and elicitation of inflammatory responses (96). Interestingly,
Heligmosomoides polygyrus and its products elicit a strong
downregulation of different CLRs including CLEC7A, 9A, 12A,
and 4N along with suppression of Syk phosphorylation (96).
In fact, it is suggested that the inhibitory effects of this worm
on CLRs and Syk expression leading to induction of regulatory
DCs in intestine and mitigation of colitis in infected mice
(96). In another way, excretory-secretory products of Taenia
crassiceps (TcES) have been found to inhibit DCs maturation in
response to TLR4 and TLR9 agonist (97). Molecular dissections
revealed that TcES are able to interfere with TLR signaling
and induce tolerogenic DCs. Terrazas et al. delineated that
TcES support Th2 response by activation of MGL, MR, and
TLR2 (97). The reported that the major intracellular mechanism
by which TcES prevent TLR4-mediate DCs maturation is by
targeting c-RAF, which is a MAP3K acting on downstream
pathways of the Ras family (97). Indeed, TcES significantly
suppress downstream molecules, such as p38 and NF-κB by
phosphorylation of c-RAF and consequently polarize immune
responses toward a Th2 phenotype (97). It has also recently
been observed that T. crassiceps-induced Ly6Chi monocyte-
derived alternatively activated macrophages (AAMs) express a
high level of MR (CD206), PD-L2, and CCR2/CX3CR1 enabling
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them to prime Tregs and suppress experimental autoimmune
encephalomyelitis in mice (98).
CLRs have also been suggested to associate with induction
of Th2 responses by Toxocara-derived antigens (99). Among
them, DC-SIGN is one of the most important receptors in
recognition of T. canis, F. hepatica, and B. malayi-derived glycan
products shaping the immune response toward a Th2/regulatory
state (100–102). Rodríguez and colleagues have recently found
that DC-SIGN plays a central role in priming Treg upon
interaction with F. hepatica-derived glycans (102). The presence
of mannose and fucose residues in F. hepatica-glycoconjugates
can facilitate DC-SIGN stimulation and trigger intracellular
pathway enabling DCs to prime Treg and inhibit proliferation
of allogeneic T cells (102). Surprisingly, stimulation of DC-
SIGN with F. hepatica-glycoconjugates activates a pathway in
DCs which, during intracellular crosstalk with TLR-mediated
signaling, induces IL-10 and IL-27 secretion in support of Treg
expansion (102). A similar mechanism has been reported for
immunoregulatory effects of F. hepatica-derived glycans upon
engagement of MGL on both human monocyte-derived DCs
(mo-DCs) and mMgl2+ CD11+ cells in mice (103). In this study,
the authors suggest that a cross regulation between pathways
due to co-stimulation of MGL and TLR4 with F. hepatica-
derived glycans and LPS, respectively, which enables DCs to
produce immunoregulatory cytokines and support Th2/Treg
proliferation (103). MR can recognize F. hepatica tegumental
antigens (FhTeg) and condition DCs to induce anergy in CD4+
T cells (104). In addition, this receptor is able to suppress
DCs maturation or Th2 induction in response to F. hepatica
total extract (105, 106). However, it is believed that MR is not
solely involved in conduction of immunosuppressive function
of FhTeg and other CLRs most likely also contribute to these
interactions (107). In support of this, F. hepatica excretory-
secretory products (FhESP) have been demonstrated to suppress
T cell activation via Dectin-1 dependent upregulation of PD-L2
and IL-10 in macrophages (108). Also, the strong suppressive
activity of FhESP has been ascribed to co-activation of MR and
Dectine-1 in macrophages underpinned by high levels of TGF-β
and IL-10 production (109).
SEA possesses an array of complex glycan-based products
which are predominantly recognized and taken up by surface
CLRs on DC including MR, MGL, DC-SIGN, and Dectin1,
triggering SYK-mediated intracellular pathways (91–93, 110).
Endocytosis of egg-derived antigens results in interference
with TLR signaling in DCs (93). The most well-known
antigens of schistosoma egg which stimulate CLRs are LEX-
containing glycans, omega-1, lacto-N-fucopentaose III and lacto-
N-neotetraose. LEX-containing glycans involve DC-SIGN on
DCs and trigger intracellular signaling, thereby promoting
Th2 responses (111). Moreover, plant-based reconstruction of
omega-1 has recently been reported to provoke Th2 responses
by engaging DC-SIGN (51). Omega-1 is a Lex-containing
glycoprotein structure representing T2 ribonuclease (RNase)
activity. The MR has also been displayed to capture and
internalize omega-1 leading to Th2 polarization along with
interfering protein synthesis via degrading host cell RNAs (112,
113). LNFPIII and lacto-N-neotetraose are potent suppressors of
T cell proliferation and DCs activation through stimulation of IL-
10 production (114). Interestingly, it has been indicated that the
immunoregulatory functions of these glycan-based biomolecules
are mediated via the MR and DC-SIGN (38, 49, 115). Of interest
is a recent study by Kooij et al. which highlighted a critical
role of MR in polarization of human classical monocytes toward
regulatory phenotype (expressing SOCS1, IL-10, and TGFβ)
upon interaction with soluble products of T. suis (TsSP) (116). In
this study, MR was found to respond to TsSP and triggers a PKC-
mediated signaling (mainly PKCδ) responsible for induction of
anti-inflammatory monocytes (116). Also, glycan compounds
in T. spiralis muscle larvae excretory-secretory antigens (ES
L1) have been reported to be able to polarize host immunity
toward Th2/Treg via corroboration of ERK1/2 signaling in DCs
and production of IL-10 and TGFβ (117). However, the major
receptor responsible for such modulation is obscure and possible
candidates need to be investigated (117).
These data suggest that CLRs can strongly react to HDPs
and condition DCs to redirect immune response toward
Th2 immunity and/or an anti-inflammatory response (118).
However, the precise shared pathway by TLRs and CLRs upon
simultaneous activation leading to release of regulatory cytokines
remains enigmatic. In the following, we discuss this topic, to
which less attention has been given.
Co-involvement of TLRs and CLRs by HDPs
Interestingly, recent data suggest that the immunomodulatory
functions of some HDPs are mediated via simultaneous
involvement of TLRs and CLRs. In fact, signaling pathways of
CLRs have shown to co-operate with TLRs which strengthen
effective immunomodulation. For example, S. mansoni secretes
glycolipids which co-involve DC-SIGN and TLR4 in human
DCs (119). Regarding intracellular crosstalk, Meyer-Wentrup
et al. suggested that TLR8-mediated production of inflammatory
cytokines, such as IL-12 and TNFα can be forestalled by dendritic
cell immunoreceptor (DCIR) as a C-type lectin receptor (120).
This complex mechanism suggests an intricate intracellular
crosstalk between two distinct receptors which results in
hyporesponsiveness and immunosuppression. Activation of CLR
signaling can modify inflammatory responses via manipulation
of TLRs signaling (121, 122). For instance, SEA and LNFPIII are
among the well-known schistosome-associated antigens which
have been reported to co-involve TLRs and CLRs in host DCs.
Egg antigens can regulate TLR2, TLR3, and TLR4 signaling
through stimulation of β-galactoside-binding lectin galectin 3
(40, 80, 123–125), while LNFPIII via interaction with DC-SIGN
and MGL1(23, 126), cross-inhibits the TLR4 pathway (101). DC-
SIGN also strongly directs the immune response toward Th2,
Treg, and modulation of inflammatory reactions. In this regard,
Geijtenbeek et al. showed that mannosylated components of
Mycobacterial cell walls diminish TLR4-associated inflammation
via DC-SIGN (122). Similarly, other pathogens seem to modify
TLR-mediated inflammatory consequences through stimulating
DC-SIGN-associated Raf-1 signaling (127).
Likewise, other glycan-based compounds released by
S. mansoni are expected to modify inflammatory responses
via co-involvement (128). The immunoregulatory activity of
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schistosome-derived lysoPS may be similar to zymosan, which
co-engages TLR2 and Dectin-1 (a type of CLRs) on DCs and
induces Treg priming along with IL-10 production (129).
Stimulation of Dectin-2 by whole extracts of S. mansoni eggs
was reported to trigger Syk and inflammasome signaling and
thereby enable inhibition of TLR signaling (110). Apart from
intracellular crosstalk, physical interaction between CLRs and
other surface receptors is believed to affect their intracellular
signaling leading to a significant modification in immune
response (128). Generally, it seems that glycan-based materials
released by helminths can modulate host immunity through
manifold signaling stemming from different receptors, such
as TLRs, CLRs, and likely other PRRs provoking both Th2
and regulatory responses (23, 130). Tracking the mechanisms
through which HDPs induce Th2 and/or regulatory responses
will provide new insight into recognition of molecules and
targets that selectively stimulate ERK signaling, which may be
beneficial in development of new generations of vaccines and
therapeutics against inflammatory diseases.
Inflammasome
Inflammasomes constitute an intracellular platform possessing
NOD-like receptor (NLR) family proteins which are highly
sensitive to various PAMPs and DAMPs (131). These cytosolic
sensors include different family of NLRPs and absent in
melanoma 2 (AIM2) which play a key role in triggering
inflammatory signals in most immune cells, but mainly in APCs
(131). Stimulation of inflammasomes results in activation of a
cascade signaling supporting active release of IL-1β and IL-18
(131). However, limited data is available on the interaction of
helminths with inflammasome, but some studies have provided
interesting results in this regard. For example, Rzepecka et al.
reported that a synthetic analog of ES-62 known as SMA-
12b is able to suppress arthritis in mice by prevention of
inflammasome activation (132). Further in-depth molecular
dissection on murine macrophages revealed the underlying
mechanisms are mediated through downregulation of IL-1β
and inflammasome-associated signals which strongly counters
inflammasome-induced responses supporting arthritis (132).
Some helminth infections and their products are able to activate
inflammasome in order to restrict production of early released
innate cytokines, such as IL-25 and IL-33 (133). For example, H.
polygyrus has been found to instigate NLRP3 in intestinal lamina
propria cells inducing IL-1β secretion and by this mechanism
prevents Th2 response initiation, ILC2 expansion, and eventually
helminth expulsion (133). The same scenario has recently been
reported for T. muris as Alhallaf et al. unraveled a novel
mechanism by which T. muris exosomes and ESP suppress anti-
parasite immunity by targeting NLRP3 (134). This study showed
that this worm and its released compounds actively counter Th2
response andworm expulsion by increasingNLRP3-mediated IL-
18 both in vivo and in vitro (134). Thus, this intracellular sensor
may be targeted by helminths to suppress Th2 responses via IL-1β
and IL-18 (133, 134).
Likewise, a well-known component from S. mansoni called
omega-1 has also shown to be able to activate NLRP3 via co-
involvement of Dectin-1 in macrophages (135). However,
it is unknown how modulating the inflammasome can
facilitate infection. In the same line, Ritter et al. studied the
inflammasome-associated activity of SEA (110). They suggested
that egg antigens can simultaneously suppress TLR signaling
and activate NLRP3. Mechanistically, egg antigens were found
to require co-activation of Dectin-1/FcγR and downstream
signaling (Syk kinase signaling) to irritate NLRP3 via activation
of reactive oxygen species and potassium eﬄux leading to IL-1β
secretion in BMDCs (100).
Targeting Non-PRR Signaling
Generally, no precise pattern of intra- and extracellular sensors
along with downstream signaling has been fully recognized
by which HDPs exert immunomodulation. Indeed, helminths
have shown to be able to exploit an array of highly complex
strategies beyond the manipulation of canonical PRRs signaling
to restore aberrant immune responses (136). In the following
section, immunosuppressive functions of some HDPs through a
PRR-independent manner will be discussed (Figure 2).
Impairment in antigen presentation, T cell receptor (TCR),
and B cell receptor (BCR) signaling
Given the myriad biomolecules released by helminths, it is not
surprising that some HDPs manipulate host immune cells via
receptor-independent manner, such as enzymatic activity. For
instance, B. malayi cystatins, such as Bm-CPI-1 (produced by
the L2 and L3 stage of B. malayi) and Bm-CPI-2 are able
to impede antigen presentation in APCs via interference with
host cysteine protease function, reducing T cell priming (136,
137). In this way, Bm-CPI-2 was reported to inhibit human
B cells to present tetanus toxoid associated peptide. Bm-CPI-
2 was shown to possess two inhibitory sites enabling it to
hinder host cysteine proteases and asparaginyl endopeptidase
(AEP) (136–138). Likewise, Onchocerca volvulus was shown
to diminish HLA-DR expression by release of onchocystatin
(139, 140). Other worms, such as Nippostrongylus brasiliensis
and Litomosoides sigmodontis produce cystatins enabling these
worms to block B cell-associated endosomal proteases and T
cell proliferation via IL-10 induction, respectively (140–143).
However, the main mechanism through which helminth-derived
cystatins affect host cells is unknown, but there is evidence
suggesting the involvement of scavenger receptors and the
transforming growth factor-β receptor (TGFβ R) pathways in
particular by Avcystatin (A. viteae-derived recombinant cystatin)
and calreticulin (a protein secreted by H. polygyrus), thereby
polarizing Th2 responses (144, 145). In support of the critical role
of helminth cystatins in promoting worm longevity, it has been
suggested that presence of anti-cystatin circulating antibodies
in mice can confine infection, suggesting that cystatins restrict
the process of antigen loading and presentation by MHCII in
APCs (141).
TCR signaling can also be affected by some HDPs in favor
of shaping immune response toward immunoregulation (146–
148). A well-known component of SEA known as omega-1 is
the best example of HDPs which directs host immunity toward
Th2 response through an intriguingmechanism.Mechanistically,
omega-1 has been found to target cytoskeletal compartments to
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FIGURE 2 | Some HDPs has been shown to target non-PRRs sensors including Kv1.3 and TCRs on T cells. Blocking Kv1.3 can significantly decrease Th1 cell
activity and proliferation. Also, presenting HDPs on the MHCII leads to induction a weak TCR signaling in naïve CD4T cells which corroborates Th2 differentiation. Of
note, the main phenotype of Th2 response elicited by helminths and their products is “modified Th2” immunity in which IL-5, IL-13, eosinophlilia, and IgE are all
downregulated, while IL-4, TGFβ, and IL-10 are increased. BCR signaling has also been shown to be impaired by some HDPs which prevent B cell activation. HDPs
have recently been more considered as magic components which are able to mimic or block several host key mediators which play an important role in
immunosuppression and Th2 amplification, respectively.
confine the formation of a stable DC-CD4+ T cell interplay,
leading to suppression of TCR signaling strength and eventually
Th2 cell differentiation. Since it has been documented that
low dose antigens, which induce a weak TCR signaling, can
prime Th2 response, the Th2-inducing property of omega-1 has
also been ascribed to this hypothesis (149). Although omega-1
is able to inhibit TLR4-mediated DC stimulation independent
of TLR-, MyD88- and TRIF, the main receptor targeted by
omega-1 is still unknown, and it is thought that its enzymatic
activity (T2 ribonuclease) likely contributes to such effects (86,
146). More investigations are required to identify whether other
S. mansoni egg-derived antigens deviate immune responses
toward Th2 by targeting TCR signaling (147). In support of
helminth-mediated TCR signaling manipulation, Appleby et al.
recently reported that in schistosome-endemic area of rural
Zimbabwe, patients infected with S. haematobium had lower
expression of CD3ζ (an integral part of TCR signaling) on
peripheral blood mononuclear cells (PBMCs) than non-infected
individuals, suggesting a possible TCR-targeted mechanism for
hyporesponsiveness and immunosuppression (150).
In comparison to omega-1, the precise interruptive effects of
ES-62 on TCR and BCR signaling have widely been determined
(148). In fact, ES-62 by degradation of key components of
downstream TCR and BCR signaling induces desensitization and
in turn restrains cell proliferation and antibody production (151).
Protein kinase C (PKC) and its different isoforms are one group
of the major molecules that play a central role in orchestration
of downstream cascade in TCR and BCR signaling for activation
of transcription factors (152). It has been documented that
ES-62 not only targets PKCs to be degraded/down-regulated
in B and T cells but also up-regulates negative regulators of
MAPKs signaling, such as RasGAP to suppress this pathway
in Jurkat T cells (153). In addition, exposure of activated
Th17 cells to LPS in the presence of ES-62 resulted in down-
regulation of MyD88 and inhibition of LPS-mediated IL-17
production (154).
IgE signaling
Some HDPs, such as Dirofilaria immitis-derived antigen (DiAg)
and Clonorchis sinensis-derived components called venom
allergen-like proteins (CsVAL) are able to impair IgE-mediated
degranulation followed by downstream signaling (155, 156).
In this way, DiAg has been demonstrated to suppress type 1
diabetes in non-obese diabetic mice via Th1 inhibition and IL-
10 induction (157). Interestingly, application of recombinant
DiAg was associated with induction of nonspecific IgE by
involving CD40 on B cells and saturation of FcεRI on mast
cells, representing protective function against passive cutaneous
anaphylaxis in rats (155). CsVAL has also displayed inhibitory
activity on IgE-mediated degranulation of mast cells via
targeting downstream pathways (156). Prevention of IgE receptor
signaling has also been observed during exposure of human
PBMCs to S. mansoni (158). It was revealed that the worm is able
to secrete a component termed as schistosome-generated (SG)
sCD23 which not only functions as a soluble decoy for the IgE
receptor but also decreases the expression of this receptor (158).
In addition, one of the well-characterized HDPs with interruptive
effects on IgE signaling is ES-62. Collectively, these molecules
might be considered as a potential therapeutic candidate in
allergic disorders.
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Mimicking and blocking host key mediators
TGFβ is one of the most powerful cytokines with
immunoregulatory activity, which stimulates naïve T cells
into regulatory T and B cells inducing immunobalance and
tolerance in mucosal tissues, such as the intestine (159). This
immunosuppressive cytokine and its receptor pathway have
been reported to be mimicked and manipulated by helminths
(159). Up to now, various components from nematodes like
A. caninum, B. malayi, H. polygyrus, and trematodes, such
as F. hepatica and the Schistosoma species have shown to
produce TGFβ homologs (159). Bm-tgh-1 and Bm-tgh-2 from
Brugia species and SmRK-1, 2, a TGF-β receptor homolog,
from S. mansoni are well-known examples of HDPs with
immunoregulatory activity due to mimicking TGFβ-induced
mechanism (159). H. polygyrus is also able to stimulate naive
T cells to express Treg-associated markers, such as Foxp3
amplifying immunoregulation via an unknown mechanism
(160). Recently, Johnston et al. have characterized an important
component from this worm known asH. polygyrus TGF-βmimic
(Hp-TGM) which is structurally similar to a member of the
complement control protein superfamily (161). Interestingly,
Hp-TGM is functionally able to ligand mammalian TGFβR
and mimic properties of TGFβ in induction of both mouse and
human Foxp3+ Treg cells (161).
Furthermore, Sulaiman et al. have recently suggested that
juvenile stages of F. hepatica release a TGF-like molecule known
as FhTLM, engaging host TGF-β receptors and triggers Smad2/3
signaling in leukocytes (162). They showed that TGF-β RII is the
main target of this component through which FhTLM increases
the production of IL-10 and PD-L1 and the mannose receptor
expression which eventually facilitate the early evasion of juvenile
by suppression host immune activation (162).
Another class of host mediators which are masterfully
mimicked by some helminths, such as S. mansoni (163), Taenia
taeniaeformis, and B. malayi are prostaglandins (PGs) (164).
Among various PGs, the immunoregulatory properties of PGE2
have widely been documented (165), and it is known that it
can modulate DC function to polarize immune response from
Th1 toward Th2 (166). Laan et al. have recently found that
T. suis releases high levels of PGE2 in its excretory-secretory
products which are likely responsible for inhibition of LPS-
induced production of inflammatory cytokines from human
DCs (25). By contrast, T. muris may expedite Th1 response
by production of IFNγ homologs to engage IFNγ receptors
leading to Th1 amplification and suppression of IL-4 mediated
responses against the worm (167, 168). Of note, the immune
response depends on the host genotype and the infection levels,
for example, resistant genotypes display Th2 response while
susceptible hosts represent Th1 response. Also, low infection
levels of T. muris elicit a Th1 and high infection induces a Th2
response (168).
Another strategy whereby helminths attenuate inflammatory
signals is production of bioactive blockers to occupy receptors
and entrap mediators triggering inflammatory responses, such
as chemokines (169). For instance, a well-known chemokine
blocker is a chemokine-binding protein which is released by
SEA called smCKBP (169). This component has been found to
be able to bind several chemokine ligands including CXCL8,
CCL2, 3, 5, and CX3CL1 resulting in suppression of both
inflammatory signals and recruitment of inflammatory cells at
the site of insult (169). Relevant to helminth-derived blocking
compounds, a very recent study by Osbourn et al. recognized a
potent IL-33 blocking component called H. polygyrus Alarmin
Release Inhibitor (HpARI) (170). Mechanistically, HpARI binds
to both nuclear DNA and mature IL-33, preventing its release
and interaction with IL-33R on airway epithelial cells and ILC2.
Further experiments in mice confirmed the suppression ability
of HpARI on IL-33 and subsequent airway allergic responses,
involving eosinophilia and IL-5 and−13 (170). These authors
revealed a novel mechanism of suppressing Th2 response onset
via inhibition of IL-33 released from necrotic epithelial cells
which are insulted during helminth infection and exposure to
airway allergens (170).
Blocking potassium voltage-gated channel (Kv1.3) on the
T cells
It has recently been shown that some HDPs can control the
function of T cells by blocking potassium voltage-gated channel
(Kv1.3) (171). AcK1 and BmK1 are a large family of Stichodactyla
helianthus toxin (ShK) composed of peptide structures secreted
by A. ceylanicum and B. malayi, respectively. These compounds
are able to block Kv1.3 channels on T cells by engaging the outer
vestibule of the channel (171). Kv1.3 channels have been proved
to widely be expressed and involved in activation of human
T cells (172). Since there are an immense number of myelin-
reactive T cells (autoreactive) resembling Kv1.3high phenotype in
multiple sclerosis (MS) forestalling these cells by targeting Kv1.3
channels would be of great interest (173, 174). In accordance with
this, some clinical trial studies have been launched to evaluate
the efficacy of AcK1 and BmK1 in attenuation of inflammation
(NCT02446340; NCT02435342).
Taken together, these data show that a complex of diverse
intracellular pathways is triggered by HDPs which ultimately
converge host immunity toward hyporesponsiveness and
immunological tolerance via manipulation of PRR-dependent
and independent strategies. Up to now, we have briefly
reviewed the intracellular interferences of HDPs as a foundation
to provide novel insights into the possible mechanisms of
extracellular vesicles (EVs) as an important component of HDPs.
In the following section, we aim to discuss the recognized
pathways utilized by EVs released during helminth infections to
bypass host immunity with the aim of proposing other unknown
mechanisms.
EXTRACELLULAR VESICLES
Biogenesis, Content, and Morphological
Properties
Various types of extracellular vesicles exist, but the structures
that are most often referred to are called exosomes, which are
30–100 nm in diameter, or microvesicles, which measure about
100–1,000 nm in diameter (175). In terms of morphological
properties and contents, exosomes are endocytic vesicles with
a spherical shape surrounded by a bilamellar membrane. Their
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contents constitute a wide variety of biomolecules including
glycans, proteins, lipids, and nucleic acids (176). Exosomes
are originally derived from endosomes via budding from
their wall, and then aggregated in a large body known as
the multivesicular body (MVB). Exosomes are unleashed in
extracellular environment upon exocytosis of MVB through
fusion with the plasma membrane (176). Apart from exosomes,
other distinct vesicles with similar function and properties can be
detected in extracellular space including microvesicles (plasma
membrane-derived microparticle) and apoptotic bodies, which
can be distinguished from exosomes in terms of biogenesis, size,
protein contents, density, and isolation technique (176). Also, the
formation of microvesicles is simpler and happens through an
outward budding of the plasmamembrane (177). Generally, all of
them are considered as EV and exosomes are the smallest EVwith
the lowest density (176). Apoptotic bodies are not the subjects of
this review and beyond our discussion.
Uptake in Recipient Cells
EVs have been acknowledged as important elements of cell-
cell communication due to their role as vehicles for molecules
and biological signals to be shuttled from one cell to another
(178). Transfer of molecules, such as protein and miRNA can
completely change the physiology of the receiving target cell and
can in this way control both normal biological processes as well
as distinct pathological processes (178).
EVs recognize and attach to their target cells through
surface proteins, such as integrins, tetraspannins, proteoglycans,
lectins, and immunoglobulins (179). The transfer of the
EV content occurs as the EVs fuse with the target cells,
which can be facilitated by various endocytic internalization
pathways and the fusion can appear as rapidly as 15min after
exposure (180). Macropinocytosis is one such mechanism where
EVs are captured and enclosed during the invagination of
ruﬄed extensions from the plasma membrane (179). Another
mechanism is phagocytosis, which is exploited by bacteria and
viruses as well as DCs and macrophages and is facilitated by
absorbing EVs by extended pseudopodia (180). Alternatively,
EVs can be taken up by clathrin-mediated endocytosis, which
involves the deformation of the target cell membrane by
clathrin on the EV surface creating an inward bud that
encloses the EVs, which can then pinch off and fuse with the
endosome (181). Calveolin-dependent endocytosis is yet another
mechanism for EV uptake where EVs oligomerize calveolin
proteins on the membrane of the target cells facilitating the
formation of intracellular calveolin-rich vesicles which then
transports the EV contents to the target site (182). Finally, under
specific conditions, EVs can fuse directly with the cell surface
membrane (183).
Parasites use this remarkable ability of EVs to communicate
with other parasite cells (parasite-parasite communication) (184)
and host cells (host-parasite communication) (185). Strong
evidence of the uptake of EVs by host cells has been obtained
for a range of parasite species, including Giardia duodenalis
(186), Leishmania major (187), Plasmodium falciparum (184),
Trichomonas vaginalis (188), Trypanosoma brucei (189), T. cruzi
(190), Echinostoma caproni (191), F. hepatica (28), H. polygyrus
(30), S. mansoni (192), A. suum, O. Dentatum, and T. suis
(Hansen et al., unpublished). Interestingly, Eichenberger et al.
have recently employed organoids from murine colonic crypts
to explore uptake of T. muris-derived EVs (193). These authors
showed that when labeled EVs are delivered into the central
lumen of organoids, they are internalized within 3 h and this
process can be inhibited upon prevention of endocytosis (193).
Furthermore, in this study transcriptomic and proteomic profile
of T. muris EVs were characterized in which a number of miRNA
with potential immunoregulatory effects on host immunity were
identified (193). Upon fusion, specifically loaded compounds and
biological signals in the EVs are transferred, which then can
exert its function in the target cell. These events are responsible
for the EV-related host immune manipulation (30, 194, 195),
pathogenesis (196, 197) and parasite development (198), that
have been reported for many parasitological diseases as described
previously.
EVs FOR THE HOST IMMUNE SYSTEM
EV-Mediated Delivery of Message by
Helminths
A number of parasites have shown to release EVs and
they have received great interest due to their remarkable
immunomodulatory properties including suppression of IL-6,
TNFα, and IL-17A in mice (191, 199, 200). Various potential
mechanisms have been suggested through which these vesicles
might affect host cells (201). In fact, they have unique biological
properties mediating cell-cell interaction both via direct contact
and/or delivering biomaterial contents affecting intracellular
crosstalk (202). However, the specific intracellular mechanisms
that are targeted remain unknown or only partially characterized.
In recent years, helminth-associated EVs have shown to
be essential mediators that contain bioactive cargo that
contribute to establishing a permissive infection (30, 202).
Apart from helminths, other microbes including fungi, bacteria,
and protozoa are able to produce EVs and mediate active
interaction with their host immunity to achieve a suitable
niche (203). The release of such a protected package can
undoubtedly optimize the integrity of contents, which in turn
improve their efficacy in genetic exchange and secure delivery
to modulate host immunity (203). Indeed, several studies
have shown that powerful biomolecules are present in the
helminth-derived EVs, which can offer potential and druggable
candidates against inflammatory diseases (204). In addition,
omics-based approaches, such as proteomics and transcriptomics
have provided a plethora of valuable data facilitating recognition
of major components mediating host immunosuppression. Such
explorations provide novel insight into previously unknown
strategies by which worms send messages to host cells to
manipulate the host immune system and may therefore also pave
the way to new ways to control infections (204–206).
Given interesting results achieved from EVs investigation,
a surge of interest has been paid to focus on their contents.
In the following, the most important biomolecules represented
by helminth EVs along with their potential implications are
discussed.
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miRNAs as an Important Player for
Intracellular Communication
One important component of EVs is miRNA, which is an
evolutionary conserved class of short non-coding RNA, of 19–
24 nucleotides in length, which plays an essential role in post-
transcriptional gene regulation and is involved in the fine-tuning
of a range of cellular processes. miRNA has been discovered in all
types of human body fluids (207) and in various different species
(208), including parasitic organisms (209, 210).
miRNA has been shown to take part in the regulation of any
kind of biological process, here among embryonic development
(211), cell differentiation and apoptosis (212–214) but also
various immunological processes (215). In fact, miRNA seems
to be involved in basically all aspects of immunological events
of both innate and adaptive character. That being differential
and activation of macrophages (216), dendritic cells (217),
granulocytes (218), NK cells (219), and other innate immune cells
(220) as well as development and function of B cells (221, 222)
and T cells (223, 224).
Recent investigations suggest that helminth EVs also contain
various RNA molecules including miRNA which may participate
to the manipulating signaling pathways which orchestrating
inflammatory responses (193). This mechanism may enable
worms to directly interfere with host gene translation and
thereby immunity to facilitate parasite survive (29, 30, 225). In
support of this, an in vitro study showed that E. multilocularis
produces a type of miRNA (emu-miR-71) which is able to
suppress NO production and inflammation-associated miRNAs
in LPS/IFN-treated murine macrophage RAW264.7 (29). By
contrast, the effects of S. japonicum-derived exosomes on the
same cell line of macrophages showed an increase of iNOS and
TNF-α, supporting M1-type macrophage development (226).
The steadily growing body of literature is supporting the
critical role of exosome-associated miRNA as an important
player involved in suppression or stimulation of target cells
(30). One of this miRNA-mediated mechanism which has
been recently suggested by Buck et al. is genetically blocking
or targeting host mRNA for degradation, causing a severe
defect in host immune response to confine worm expulsion.
Molecular digestion showed that this miRNA is able to target
3′ untranslated region of the mRNA encoding Th2-associated
cytokines, such as IL-33 which in turn prevents the ILC2
expansion and eliciting a strong Th2 response (30). Thus, it seems
that helminths possess EVs with bioactive compounds, such as
miRNAs that are able to effectively neutralize host immunity
and polarize immune responses toward the way supporting their
survival.
Gu et al. also suggest that some helminth miRNAs only might
target host genes and that their release is a selective process
as the profile of released miRNAs in the excretory-secretory
products differed from that of adult extracts of Haemonchus
contortus (227).
In addition to miRNA, other RNA molecules have been
identified within helminth EVs, such as mRNA and tsRNA
(193, 228) but their potential function and role in host-parasite
interaction still need to be elucidated.
Proteins and Lipids in EVs
In addition to nucleic acid, EVs do also contain a diverse
collection of molecules including lipids and proteins (229, 230).
The protein composition has been characterized in excretory-
secretory products from several parasite species using proteomic
approaches based on mass spectrometry and has shown that it
contains a suite of immunomodulatory proteins with immune
suppressive effects e.g., on type 1 and type 2 effector molecules
(30, 231–233).
Proteins identified in EVs comprise several peptidases,
proteases, cytoskeletal proteins, nuclear proteins, calcium-
binding proteins as well as stress-related proteins (28, 234, 235).
Importantly, Coakley et al. demonstrated that H. polygyrus
secretes EVs containing Argonaute protein, which is a central
protein in the RNA-induced silencing complex (RISC) and is a
powerful mechanism of gene silencing (229, 236). Furthermore,
EVs are expected to be an important part of the secretome
and it has been shown that the secreotomes of many helminths
contain a variety of highly-abundant leaderless proteins, which
is homolog to damage-associated molecular pattern molecules
(DAMPs) in the host (28, 197). These DAMPs can, just like the
host’s DAMPs, modulate the host innate cells, such as stimulation
of cytokine secretion in macrophages and lymphocytes. This
could indicate that helminths have evolved mechanisms that are
similar to their hosts in order to avoid elimination by the immune
response of the hosts (182, 237).
Interestingly, besides parasite proteins, EVs have also been
shown to contain host-derived proteins. Marcilla et al. identified
36 different host proteins in vesicles from the trematode
E. caproni, which mainly corresponded to histones, partial
sequences of mucins, metabolic enzymes, and immunoglobulins
(28). Their study suggests that EVs might be an important part of
the host-parasite communication as host proteins were identified
in the parasite EVs and as the vesicles were taken up by host
cells. These findings are interesting, however further studies are
needed to confirm the role of the vesicles for the establishment
of the infection (28). Very recently a similar study has been
conducted by Eichenberger et al. in which proteomic profile
of T. muris-derived EVs also identified a number of proteins
of importance in host-parasite interaction. Of interest, among
the common most proteins were predicted not to have a signal
peptide supporting the idea that EVs constitute an important
mechanism by which molecules are transferred to the host (193).
Surprisingly, several studies have shown that a significant
proportion of the EV proteins are lacking an N-terminal
presequence, also referred to as transit peptide. The transit
peptide is required for protein transport across relevant
membranes and indicates a protein transport through a classical
sorting pathway via ER/Golgi pathway (238). Since a significant
proportion of the parasite proteins are lacking the transit peptide,
this suggests that EVs may be an important mechanism for
transport of proteins host cells (28, 185, 239).
Lipids are a major component of EVs and play an important
role in the function, stability, rigidity, and uptake of EVs, as they
are directly exposed to the environment. Most of the lipidomic
studies have been performed in cancer cells and these studies have
indicated that EVs may have a function as lipid carriers where
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they carry bioactive lipids to recipient cells. In the context of the
tumor microenvironment, this transport may have an effect on
the enrichment of tumor progression and immunosuppressive
lipids, such as prostaglandins that enhance tumor growth (240,
241). Even though lipids are central to EV trafficking, only a few
studies have yet explored the lipid content of EVs in parasites and
their specific role remain to be elucidated (242, 243).
EVs AS NOVEL VACCINES
Even though helminth parasites infect over 25% of the world’s
population and are highly prevalent in livestock worldwide, these
infections are one of the most “neglected” tropical diseases with
no effective vaccines available for humans and only a few for
animals (244, 245). The use of EVs as vaccines is an area of
growing interest due to their immunomodulation role and EVs
ability to generate specific antibodies (30, 191, 202).
Using EVs purified from Echinostoma caproni, Trelis et al.
found that subcutaneous injection could reduce symptom
severity and mortality of subsequent experimental infection in
mice (191). Likewise, EV vaccination in mice generates specific
antibodies and was sufficient to confer protective immunity
against H. polygyrus challenge (202). T. muris-derived EVs has
also recently been found to confer protection against subsequent
infection (246). Several proteins were identified in the T.
muris EVs and some proposed to be potential candidates for
vaccine (246).
However, further studies are needed to further explore the
potential of parasite-derived EVs as novel vaccine candidates
(206). In another approach, DCs have been stimulated or infected
with protozoan parasites following isolation of EVs, which then
have been tested as vaccines. In this way, DC-derived EVs have
shown to confer protective immunity against Toxoplasma gondii
(247), Leishmania major (248).
Sotillo et al. observed that 31% of the identified proteins in
EVs secreted from S. mansoni are homolog to previous describes
vaccine candidates, where several of these proteins are common
throughout the life cycle of the parasite. This indicates that a
vaccine based on EVs could target different life stages of the
parasite and may be effective against S. mansoni infection (249).
However, EVs are biological complex and virtually nothing is
known about their specific mechanisms and how they engage
with the immune system. However, it was recently demonstrated
that EVs from H. polygyrus are able to suppress both the
activation of macrophages and target the Il-33 pathway, which is
known to be essential for worm expulsion (202). Taken together,
all these observations indicate that EVs hold a great potential for
future vaccine development, and thereby pave the way for novel
treatment options against parasite infection (206).
EVs AS NOVEL GENERATION OF
BIOMARKERS: POSSIBILITIES AND
POTENTIALS FOR EARLY DIAGNOSIS OF
PARASITIC INFECTIONS
EVs have shown to contain a rich source of molecules and as
these are protected from the environment by a membrane they
are stable over time (250). In addition, as EVs are distributed in
various body fluids and organs, they have received great interest
for biomarker-based diagnosis (250). Indeed, the potential of EVs
as a biomarker has widely been investigated in the field of cancers
and the contents of exosomes derived from ovarian cancer
patients have shown to differ from that of healthy individuals
(250). Interestingly, some cancer types are associated with
specific miRNA signatures in the exosomes and may, therefore,
serve as a novel way of diagnosis and monitoring progression of
treatment (251, 252). In infectious diseases, EVs isolated from
serum samples have also shown potential in diagnostics (253).
However, the physical location of the pathogen may affect the
applicability of this method or at least the way samples should
be collected. Buck et al. found that miRNA of Litomosoides
sigmodontis, which is located in the pleural cavity, could be
identified in the host serum whereas no miRNA of H. polygyrus,
which resides in the gut lumen could be detected (30).
With the advent of high throughput assays, which now
also includes EV array (254), a profound understanding is
being established regarding host-parasite interplay and the main
pathway by which EVs target host immune cells. Proteomics
analysis on the HDPs concentrated in EVs has provided
invaluable data to identify and purify the central candidate
components for biomarkers, diagnostic tools, and vaccine
development (255, 256). Likewise, HDPs merely have shown
an acceptable potential to be considered as an approach to
early infection diagnosis (257). For instance, cathepsin B1 from
Opisthorchis viverrini has shown a potential candidate for further
consideration as a biomarker in sera (258).
Altogether, the release of EVs might be a reciprocal beneficial
interaction for both host and helminths. Eliciting an effective
immune response against EVs is an obvious reason for the
presence of highly immunogenic components which may offer
possible biomarker candidate. On the other hand, helminths
constantly explore a way to defeat host immunity and set up a
permissive infection which production of EVs containing various
types of material is might be a strong strategy (Figure 3).
PERSPECTIVES
Until now, many different and highly complex mechanisms have
been suggested for immunosuppressive functions of HDPs. But,
given the advances in recognition of EVs and their importance
as an effective tool in manipulation of host immune cells, it
makes sense to suppose the possible involvement of EVs in most
HDPs-mediated immunomodulation.
Main intracellular pathways manipulated by HDPs were
reviewed, but limited information has been provided regarding
interaction between helminth-derived EVs and immune cells.
Although several investigations have recently reported the
potential intracellular functions of EVs, they are only partially
characterized. Given the different mechanisms by which EVs
are taken up by recipient cells (discussed in EV section), future
investigations should focus on the intracellular mechanisms and
pathways responsible for immunosuppression.
We believe that most mechanistic pathways which have been
reported for HDPs can be tracked for EVs and their contents.
Most biomolecules form contents of EVs require to reach into
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FIGURE 3 | Schematic illustration of known effects imposed by helminth-derived EVs during interaction with host immunity. As illustrated here, EVs can affect different
host cells including immune cells and intestinal epithelial cells (IECs). Also, they can potentially be used to develop new vaccines against helminths. EVs deliver cargo
containing various biomolecules to host cells which can interfere with host cell gene transcription. EVs are internalized by macrophages and IECs via unknown
mechanism and target IL-33R and DUSP1 expression reducing signal transmission and leads to inhibition of helminth expulsion. EVs have also shown great potential
in priming host immunity along with Alum as a vaccine complex against helminth infections. Effective suppression of both classical Mφ and AAMφ have also been
reported, implying EVs are well-equipped with a wide range of active components. In addition to in vitro studies, immunomodulatory functions of EVs have also been
monitored in in vivo model in which allergic responses, associated cytokines, ILC2, and eosinophilia are down-regulated in Alternaria-exposed mice.
the recipient cells to show their functions. The intracellular and
PRR-targeting mechanisms of HDPs which were discussed in this
review provide a framework to explore the possible interaction
between EVs contents and intracellular components. In this
regard, study on the PRRs-EV interplay would be of great interest
to address some of the intracellular effects mediated by EVs.
Release of EVs cargo in host immune cells can be associated
with various outcomes, so determining the potential interaction
between EVs cargo and PRRs downstream signaling would be
valuable. For instance, Kojima et al. (259) showed that mesenteric
lymph is able to exacerbate inflammatory responses via activation
of TLR4 on macrophages without uptake through this receptor.
They also showed that TLR4 signaling pathway is essential for
exosome-induced macrophage activation (259).
EVs have recently been considered as a promising option to
tune immune responses, as well as reprogram aberrant reactions
to innocuous antigens. With respect to this, unraveling the main
components of helminth-derived EVs, which are responsible
for host immunomodulation may offer personalized therapeutic
approaches in translational medicine.
Also, from a diagnostic point of view, EVs released by
helminths may pave the way for developing a rapid diagnostic
test that also can detect early parasitic infection. In addition,
recognition and targeting main players in the biogenesis of
helminth-derived EVs will be associated with novel insights
into control of parasitic infections. Obviously, suppression of
EVs synthesis containing a wide array of bioactive components
will neutralize one of the central mechanism of helminths to
overcome host immunity. Interestingly, interfering with EVs
biogenesis with exploiting selective inhibitors has provided
promising results in the field of cancer therapy (260), but the
applicability of this approach to combat helminth infections
remains elusive. However, several investigations have been
conducted to assess the potential of protozoan EVs for vaccine
development against toxoplasmosis and leishmaniasis (248, 261).
In these studies, exosomes derived from DCs exposed to parasite
antigens have shown to be able to protect against infection in
experimental models. Collectively, it seems that the importance
of EVs and their relevance in establishment of a chronic infection
are less-known and eagerly awaited to precisely be unraveled in
the near future.
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